Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-10-30
1999-02-23
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
058744711
ABSTRACT:
This invention is a novel method in orthomolecular health to sustain favorable amounts of L-arginine efficiently within the human body for preservation of good health and amelioration of various disease states. The method provides administration of sizable amounts of L-citrulline as precursor substance for bioconversion to L-arginine in order to maintain greater blood plasma concentrations of L-arginine as potential substrate for various metabolic functions. The method is useful to increase the availability of substrate for nitric oxide production by constitutive nitric oxide synthases. Embodiments include uses of exogenous L-citrulline for more vasoprotection in sickle cell disease and atherosclerosis, more stability in circulating platelets, more relaxative smooth muscle tone during pregnancy and in achalasia, greater defense against angiostenosis after angioplasty, greater defense against oxidative stress, enhanced cell stores of creatine, enhanced fertility in males with oligospermia, and greater defense against osteoporosis.
REFERENCES:
Pauling, L., "Orthomolecular Somatic and Psychiatric Medicine", Vitalstoffe Zivilisationskrankheiten, 13:3-5 (1968).
Visek, W.J., "Arginine and Disease States," J.Nutr., 115:532-541 (1985).
Barbul, A., "Arginine: Biochemistry, Physiology, and Therapeutic Implications", J. Parenteral Enteral Nutr. 10:227-238 (1986).
Young, V.R. et al, pp. 191-232 (Chapter 13) in: Amino Acid Metabolism and Therapy in Health and Nutritional Disease, ed. by L.A. Cynober, CRC Press (1995).
Rothnagel, J.A. et al, "Citrulline in Proteins from the Enzymatic Determination of Arginine Residues", in: Methods in Enzymology, 107(B), Academic Press (1984), pp. 624-631.
Schmidt, H.H.H.W. et al, "No at Work", Cell 78:919-925 (1994).
Windmueller, H.G. et al, "Source and Fate of Circulating Citrulline", Am. J. Physiol. 241:E473-E480 (1981).
Jones, M.E., "Conversion of Glutamate to Ornithine and Proline: Pyrroline-5-Carboxylate, a Possible Modulator of Arginine Reguirements", J. Nutr. 115:509-515 (1985).
Dhanakoti, S.N. et al, "Renal Arginine Synthesis:Studies in vitro and vivo", Am. J. Physiol. 259:E437-E442 (1990).
Castillo, L. et al, "Plasma Arginine and Citrulline Kinetics in Adults Given Adequate and Arginine-free Diets", Proc. Natl. Acad. Sci. USA 90:7749-7753 (1993).
Kamoun, P. et al, "Citrulline Concentrations in Human Plasma after Arginine Load", Clin. Chem. 37:1287 (1991).
Noeh, F.M. et al, "The Effects of Arginine Administration on the Levels of Arginine, Other Amino Acids and Related Amino Compounds in the Plasma, Aorta, Vena Cava, Bronchi and Pancreas of the Rat", Life Sciences 58:PL131-138 (1996).
Yearick, E.S. et al, "Serum Amino Acid Response to Isocaloric Test Meals", Am. J. Clin. Nutr. 20:338-344 (1967).
Palmar, T. et al, "The Effect of Protein Loads on Plasma Amino Acid Levels", Clin. Sc. Molec. Med. 45:827-832 (1973).
Smoyer, W.E. et al, "Enhanced GFR Response to Oral Versus Intravenous Arginine Administration in Normal Adults", J. Lab. Clin. Med. 118:166-175 (1991).
Armstrong, M.D. et al, "A Study of Plasma Free Amino Acid Levels. II. Normal Values for Children and Adults", Metab. 22:561-569 (1973).
Perry, T.L. et al, "CSF Amino Acids and Plasma--CSF Amino Acid Ratios in Adults", J. Neurochem. 24:587-589 (1975).
Scriver, C.R. et al, "Normal Plasma Free Amino Acid Values in Adults: The Influence of Some Common Physiological Variables", Metab. 34:868-873 (1985).
Fitch, W.L. et al, "Plasma Amino Acid, Glucose, and Insulin Responses to Moderate-Protein and High-Protein Test Meals in Pregnant, Nonpregnant, and Gestational Diabetic Women", Am. J. Clin. Nutr. 46:243-249 (1987).
Moriguti, J.C. et al, "Fasting Plasma Free Amino Acid of Elderly Men", Amino Acids 9:46 (1995).
Forstermann, U. et al, "Nitric Oxide Synthase Isozymes", Hypertension 23:1121-1131 (1994).
Radomski, M.W. et al, "An L-Arginine/Nitric Oxide Pathway Present in Human Platelets Regulates Aggregation", Proc. Natl. Acad. Sci. USA 48:5193-5197 (1990).
Muruganandam, A. et al, "Isolation of Nitric Oxide Synthase from Human Platelets", Biochim. Biophys. Acta 1200:1-6 (1994).
Vasta, V. et al, "Identification of a Specific Transport System for L-Arginine in Human Platelets", Biochem. Biophys. Res. Commun. 206:878-884 (1995).
Moncada, S. et al, "The L-Arginine/Nitric Oxide Pathway", New Engl. J. Med. 329:2002-2012 (1993).
Mayer, B. et al, "Biosynthesis of Endothelium-Derived Relaxing Factor: A Cytosolic Enzyme in Porcine Aortic Endothelial Cells Ca2+--Dependently Converts L-Arginine into an Activator of Soluble Guanyl Cyclase", Biochem. Biophys. Res. Commun. 164:678-685 (1989).
Arnal, J.-F. et al, "Intractions between L-Arginine and L-Glutamine Change Endothelial No Production", J. Clin. Invest. 95:2565-2572 (1995).
Bogle, R.G. et al, "Bradykinin and ATP Stimulate L-Arginine Uptake and Nitric Oxide Release in Vascular Endothelial Cells", Biochem. Biophys. Res. Commun. 180:926-932 (1991).
Drexler, H. et al,"Correction of Endothelial Dysfunction in Coronary Microcirculation of Hypercholesterolaemic Patients by L-Arginine", Lancet 338:1546-1550 (1991).
Creager, M.A. et al, "L-Arginine Improves Endothelium-Dependent Vasodilation in Hypercholesterolemic Humans",J. Clin. Invest. 90:1248-1253 (1992).
Cooke, J.P. et al, "Antiatherogenic Effects of L-Arginine in the Hypercholesterolemic Rabbit", J.Clin. Invest. 90:1169-1172 (1992).
Tsao, P.S. et al, "Enhanced Endothelial Adhesiveness in Hypercholesterolemia is Attenduated by L-Arginine", Circulation 89:2176-2182 (1994).
Cooke, J.P. et al, "Cellular Mechanisms of Atherogenesis and the Effects of Nitric Oxide", Current Opinion Cardiol. 7:799-804 (1992).
Becker, R.C., "Antiplatelet Therapy", Sci. Med. 3:12-21 (1996).
Zeiher, A.M. et al, "Endothelium-Mediated Coronary Blood Flow Modulation in Humans", J. Clin. Invest. 92:652-662 (1993).
Bucala, R. et al, "Advanced Glycosylation Products Quench Nitric Oxide and Mediate Defective Endothelium-dependent Vasodilatation in Experimental Diabetes", J. Clin. Invest. 87:432-438 (1991).
Compo, C. et al, "Aging Abolishes the Renal Response to L-Arginine Infusion in Essential Hypertension", Kidney Intern. 49 (Suppl. 55):S-126--S-128 (1996).
Wu, K.K. et al, "Role of Endothelium in Thrombosis and Hemostasis", Annu. Rev. Med. 47:315-331 (1996).
Hamon, M. et al, "Long-term Oral Administration of L-Arginine Reduces Intimal Thickening and Enhances Neoendothelium-dependent Acetylcholine-induced Relaxation after Arterial Injury", Circulation 90:1357-1362 (1994).
Harker, L.A. et al, "The Role of Platelets in Acute Vascular Events", Circulation 62:Suppl. V, V-13--V-18 (1980).
Lloyd-Jones, D.M. et al, "The Vascular Biology of Nitric Oxide and Its Role in Atherogenesis", Annu. Rev. Med. 47:365-375 (1996).
Martindale The Extra Pharmacopoeia, 30 th. edition, ed. by J.E.F. Reynolds, Pharmaceutical Press, (1993) pp. 1038, 1517, 1582, 1649, 1770, 1839, 1914, 2037.
Francis, R.B. Jr. et al, "Vascular Occlusion in Sickle Cell Disease: Current Concepts and Unanswered Questions", Blood 77:1405-1515 (1991).
Wolters, H.J. et al, "Low-intensity Oral Anticoagulation in Sickle-Cell Disease Reverses the Prethrombotic State: Promises for Treatment?", Brit. J. Haematol. 90:715-717 (1995).
Steinberg, M.H., "Review: Sickle Cell Disease: Present and Future Treatment", Am. J. Med. Sci. 312:166-174 (1996).
Schoengold, D.M. et al, "Free Amino Acids in Plasma Throughout Pregnancy", Am. J. Obstet. Gynecol. 131:490-499 (1978).
Dorner, K. et al, "Referenzwerte fur Plasmaaminosauren im Verlauf der Schwangerschaft", Z. Geburtsh. u. Perinat. 197:141-143 (1993).
MacDonald, P.C. et al, "Preterm Birth", Scient. Am. Sci. Med. 3:42-51 (1996).
Roberts, J.M. et al, "Preclampia: an Endothelial Cell Disorder", Am. J. Obstet. Gynecol. 161:1200-1204 (1989).
Molnar, M. et al, "Prolonged Blockage of Nitric Oxide Synthesis in Gravid Rats Produces Sustained Hypertension, Proteinuria, Thrombocytopenia, and the Intrauterine Growth Retardation", Am. J. Obst. Gynecol. 170:1458-1466 (1994).
Egashira, K. et al, "Evidence of Impaired Endothelium-dependent Coronary Vasodilation in Patients wi
LandOfFree
Orthomolecular medical use of L-citrulline for vasoprotection, r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orthomolecular medical use of L-citrulline for vasoprotection, r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orthomolecular medical use of L-citrulline for vasoprotection, r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307567